Doubling Down Following up on our recent white paper, Biopharma’s COVID Capital Comeback, here is a look at the greatest risk […]
Q3 2020 Report: Global Trends in Biopharma Transactions Each quarter our team at Locust Walk compiles key statistics and trends on strategic
Q3 2020 Report: Global Trends in Biopharma Transactions Each quarter our team at Locust Walk compiles key statistics and trends on strategic
Panel Recording! Knocking SUBSCRIBE TO OUR INSIGHTS Linkedin Twitter Youtube Instagram CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk
Biopharma’s COVID Capital Comeback What a difference a few months can make – especially during a pandemic. Heading into 2020,
Biopharma’s COVID Capital Comeback What a difference a few months can make – especially during a pandemic. Heading into 2020,
CATEGORIES News Events Publications ARCHIVE Panel Recording: The Unexpected IPO Boom in Biopharma in Q2 Locust Walk partnered with Applied
CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk Institute Market Trends Multitrack Process Negotiation Partnering Quarterly Reports Live Panel:
The Unexpected IPO Boom for Biopharma in Q2 SUBSCRIBE TO OUR INSIGHTS Linkedin Twitter Youtube Instagram CATEGORIES News Locust Walk
Global Trends in Biopharma Transactions Q2 2020 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk deal team members